COMPREHENSIVE APPROACH TO THE TREATMENT AND PREVENTION OF NON-ALCOHOLIC FATTY LIVER DISEASE
Article Sidebar
This work is licensed under a Creative Commons Attribution 4.0 International License.
Main Article Content
Abstract:
Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent and pressing issues in modern medicine, closely associated with the increasing prevalence of obesity and metabolic syndrome. This article describes a comprehensive approach to the treatment and prevention of NAFLD, incorporating various strategies aimed at correcting metabolic disorders and improving patients' quality of life.
Article Details
How to Cite:
References:
Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clinic proceedings Mayo Clinic 1980;55(7):434–438.
Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012;55(6):2005–2023.
Мирзакаримова Ф.Р., Каледа С.П., Поликарпова Н.В. Неалкогольная жировая болезнь печени – некоторые аспекты профилактики. Uzbek Medical Jornal 2021;
Babajanov A. S., Mirzakarimova F.R., Kaleda S.P., Modern Views About The Main Risk Factors And Prevention Of Fatty Hepatosis; Science And Innovation International Scientific Journal Volume 2 Issue 12 December 2023; 542-546.
Клинические рекомендации. Неалкогольная жировая болезнь печени. Российское общество по изучению печени,2024г.